• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    52 Biggest Movers From Friday

    1/18/22 5:26:50 AM ET
    $ADCT
    $ADGI
    $APT
    $ATIP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADCT alert in real time by email

    Gainers

    • Splash Beverage Group, Inc. (NASDAQ:SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) rose 54.3% to close at $1.62 after the company announced the planned expansion of its Robotics as a Service offering with the proposed acquisition of Shenzhen Keweien Robot Service Co. and Guangzhou Kewei Robot Technology Co.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) shares jumped 27% to close at $20.87.
    • ATI Physical Therapy, Inc. (NYSE:ATIP) shares surged 23.4% to close at $3.75 on Friday after Jefferies upgraded the stock from Hold to Buy and raised its price target from $3.50 to $5.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) rose 23.2% to settle at $11.73. Theseus Pharmaceuticals recently said first patient was treated with THE-630 in Phase 1/2 study in patients with advanced gastrointestinal stromal tumors.
    • ShiftPixy, Inc. (NASDAQ:PIXY) gained 22.9% to close at $1.29.
    • Integrated Media Technology Limited (NASDAQ:IMTE) surged 19.8% to close at $8.77. Integrated Media Technology recently entered into convertible note purchase agreements with eight individual investors to raise $10 million.
    • Prometheus Biosciences, Inc. (NASDAQ:RXDX)gained 17.1% to settle at $35.29.
    • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) shares jumped 16.6% to close at $11.10. Shares of Macau casino stocks traded higher following the release of a new Macau gaming bill that was mostly in-line with expectations but that had at least a couple of bullish surprises for investors.
    • Cardiol Therapeutics Inc. (NASDAQ:CRDL) gained 16.3% to close at $2.00.
    • Ucommune International Ltd (NASDAQ:UK) jumped 15.4% to settle at $0.90. Ucommune International recently signed an agreement with Nanchang Qinghu Industrial Park Management Company to jointly develop the Nanchang Honggutan-Ucommune project.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) rose 15.3% to close at $4.07 after gaining around 23% on Thursday.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 15.2% to close at $0.7804 following Q3 results. NextPlay Technologies reported quarterly gross profit of $2.2 million and sales of $4.2 million.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) jumped 14.6% to settle at $0.4240.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) gained 14.3% to close at $0.72.
    • Las Vegas Sands Corp. (NYSE:LVS) rose 14.2% to close at $42.99. Shares of Macau casino stocks traded higher following the release of a new Macau gaming bill that was mostly in-line with expectations but that had at least a couple of bullish surprises for investors.
    • SmileDirectClub, Inc. (NASDAQ:SDC) gained 14.2% to settle at $2.25.
    • Fathom Digital Manufacturing Corporation (NYSE:FATH) gained 13.9% to close at $7.89.
    • Planet Labs PBC (NYSE:PL) gained 13.8% to close at $6.36.
    • Indonesia Energy Corporation Limited (NYSE:INDO) rose 13.2% to close at $3.28.
    • Reliance Global Group, Inc. (NASDAQ:RELI) jumped 13% to settle at $8.96.
    • Molecular Partners AG (NASDAQ:MOLN) shares gained 12.7% to close at $31.89. Molecular Partners said Essex Woodlands Health Ventures Funds crossed below the 3% threshold, transacting its remaining shares to BVF Partners L.P., whose holdings have now crossed the 10% threshold, rising to 12.21%. The company has licensed its COVID-19 treatment candidate to Novartis.
    • Zovio Inc (NASDAQ:ZVO) gained 12.3% to settle at $1.37. Zovio's Fullstack Academy recently reported a partnership with upGrad to introduce cybersecurity, data analytics bootcamps in India.
    • Wynn Resorts, Limited (NASDAQ:WYNN) rose 8.6% to close at $91.47. Shares of Macau casino stocks traded higher following the release of a new Macau gaming bill that was mostly in-line with expectations but that had at least a couple of bullish surprises for investors.
    • Adagio Therapeutics, Inc. (NASDAQ:ADGI) gained 8.4% to close at $5.70. Adagio Therapeutics recently summarized recent findings reported in three separate publications that show ADG20 has neutralization activity against Omicron.

     

    Check out these big penny stock gainers and losers

    Losers

    • Cerberus Cyber Sentinel Corp (NASDAQ:CISO) shares dropped 25% to close at $5.42 on Friday. Cerberus Cyber Sentinel priced its initial public offering of 2,000,000 shares stock at a price of $5.00 per share.
    • Weidai Ltd. (NYSE:WEI) shares declined 20.5% to settle at $0.5801. Weidai said it will change the ratio of its American depositary shares.
    • Smith-Midland Corporation (NASDAQ:SMID) dropped 16.8% to close at $27.38.
    • FTC Solar, Inc. (NASDAQ:FTCI) shares fell 15.6% to close at $5.13 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $9 to $5.
    • Dingdong (Cayman) Limited (NYSE:DDL) dipped 14.8% to settle at $8.63. The company’s board, last month, authorized a share repurchase program of up to $30.0 million of its shares.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) dropped 13.7% to close at $0.3850.
    • Insignia Systems, Inc. (NASDAQ:ISIG) fell 13.6% to close at $19.40.
    • Vaccitech plc (NASDAQ:VACC) dipped 13.3% to settle at $9.95.
    • GWG Holdings, Inc. (NASDAQ:GWGH) dropped 13.1% to close at $7.82.
    • Kelso Technologies Inc. (NYSE:KIQ) dipped 12.7% to close at $0.4801.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) fell 12.5% to settle at $0.6871. Journey Medical recently acquired Molecule Stabilizing Technology (MST) franchise, including Amzeeq (minocycline) topical foam and Zilxi (minocycline) topical foam from VYNE Therapeutics.
    • Codex DNA, Inc. (NASDAQ:DNAY) dipped 12.5% to close at $7.54. Codex DNA recently signed early access collaboration and licensing agreement with Pfizer to further develop Codex DNA's Novel Enzymatic DNA synthesis technology for Pfizer's use in its research and development of mRNA-based vaccines and biotherapies.
    • Nxt-ID, Inc. (NASDAQ:NXTD) fell 12.1% to close at $3.28.
    • Brilliant Earth Group, Inc. (NASDAQ:BRLT) declined 10.8% to close at $12.42.
    • Alpha Pro Tech, Ltd. (NYSE:APT) dropped 10.4% to close at $5.44.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) fell 10.3% to close at $6.90. Revelation Biosciences reported data demonstrating REVTx-99 in vitro anti-viral activity against SARS-CoV-2.
    • iSpecimen Inc. (NASDAQ:ISPC) dipped 10.1% to close at $6.25. iSpecimen, on Thursday, announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) fell 9.4% to close at $14.13. SOPHiA GENETICS recently reported strong traction in the launch phase of their DEEP-Lung-IV clinical study.
    • CureVac N.V. (NASDAQ:CVAC) fell 9.4% to close at $24.48.
    • ADC Therapeutics SA (NYSE:ADCT) fell 9.3% to close at $17.22.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) fell 9.1% to close at $8.55.
    • Orchid Island Capital, Inc. (NYSE:ORC) shares fell 7.9% to close at $4.22. Orchid Island Capital sees Q4 book value of $4.34 per share.
    • Perella Weinberg Partners (NASDAQ:PWP) fell 7.5% to close at $11.86 after the company announced a public offering of 3,500,000 shares of common stock.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) shares fell 7.4% to close at $4.64 after jumping over 25% on Thursday.
    • Imago BioSciences, Inc. (NASDAQ:IMGO) fell 7.4% to close at $18.48.
    • JPMorgan Chase & Co. (NYSE:JPM) dropped 6.2% to close at $157.89 after reporting Q4 results.
    • PagSeguro Digital Ltd. (NYSE:PAGS) fell 4.7% to settle at $22.45. Keybanc downgraded PagSeguro Digital from Overweight to Sector Weight.
    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $ADGI
    $APT
    $ATIP

    CompanyDatePrice TargetRatingAnalyst
    Perella Weinberg Partners
    $PWP
    4/8/2026$21.00Mkt Perform → Outperform
    Keefe Bruyette
    Las Vegas Sands Corp.
    $LVS
    4/6/2026$61.00Buy → Hold
    Jefferies
    JP Morgan Chase & Co.
    $JPM
    3/26/2026$310.00Hold
    Jefferies
    FTC Solar Inc.
    $FTCI
    3/6/2026$12.50 → $8.00Buy
    TD Cowen
    Brilliant Earth Group Inc.
    $BRLT
    3/6/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Brilliant Earth Group Inc.
    $BRLT
    3/6/2026$1.50Buy → Neutral
    B. Riley Securities
    Melco Resorts & Entertainment Limited
    $MLCO
    2/17/2026$9.50Neutral → Buy
    UBS
    JP Morgan Chase & Co.
    $JPM
    2/3/2026$280.00Underperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ADCT
    $ADGI
    $APT
    $ATIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Perella Weinberg Partners upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Perella Weinberg Partners from Mkt Perform to Outperform and set a new price target of $21.00

    4/8/26 8:24:15 AM ET
    $PWP
    Finance: Consumer Services
    Finance

    Las Vegas Sands downgraded by Jefferies with a new price target

    Jefferies downgraded Las Vegas Sands from Buy to Hold and set a new price target of $61.00

    4/6/26 8:31:30 AM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    Jefferies initiated coverage on JPMorgan Chase with a new price target

    Jefferies initiated coverage of JPMorgan Chase with a rating of Hold and set a new price target of $310.00

    3/26/26 8:49:56 AM ET
    $JPM
    Major Banks
    Finance

    $ADCT
    $ADGI
    $APT
    $ATIP
    SEC Filings

    View All

    Orchid Island Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Orchid Island Capital, Inc. (0001518621) (Filer)

    4/23/26 4:55:50 PM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    SEC Form 8-K filed by JP Morgan Chase & Co.

    8-K - JPMORGAN CHASE & CO (0000019617) (Filer)

    4/23/26 4:15:28 PM ET
    $JPM
    Major Banks
    Finance

    SEC Form FWP filed by JP Morgan Chase & Co.

    FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

    4/22/26 6:24:50 PM ET
    $JPM
    Major Banks
    Finance

    $ADCT
    $ADGI
    $APT
    $ATIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Orchid Island Capital Announces First Quarter 2026 Results

    VERO BEACH, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid" or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended March 31, 2026. First Quarter 2026 Results Net loss of $(20.0) million, or $0.11 per common share, which consists of:Net interest income of $57.1 million, or $0.30 per common shareTotal expenses of $7.4 million, or $0.04 per common shareNet realized and unrealized losses of $69.6 million, or $0.37 per common share, on RMBS and derivative instruments, including net interest income on interest rate swapsFirst quarter dividends declared and paid of $0.36 per com

    4/23/26 4:05:00 PM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    Las Vegas Sands Reports First Quarter 2026 Results

    For the quarter ended March 31, 2026Net Revenue Increased 25.3% to $3.59 billionNet Income Increased 57.1% to $641 millionDiluted Earnings per Share Increased 73.5% to $0.85 per Share Consolidated Adjusted Property EBITDA Increased 24.6% to $1.42 billionLVS Repurchased $740 million of Common StockLAS VEGAS, April 22, 2026 /PRNewswire/ -- Las Vegas Sands (NYSE:LVS), the leading global developer and operator of Integrated Resorts, today reported financial results for the quarter ended March 31, 2026."We continued to execute our strategic objectives during the quarter as we delivered growth in both Singapore and Macao while continuing to increase the return of capital to shareholders," said Pat

    4/22/26 4:05:00 PM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    Wynn Resorts Releases 2025 ESG Report Highlighting Sustainability, Workforce Development and Community Impact

    LAS VEGAS, April 21, 2026 /PRNewswire/ -- Wynn Resorts (NASDAQ:WYNN), a global leader in luxury hospitality, today announced the release of its 2025 Environmental, Social and Governance (ESG) Report and Executive Overview, detailing the Company's environmental sustainability, workforce development and community impact initiatives across its North American operations. The Wynn Resorts ESG Report 2025 highlights continued investment in employee development, measurable improvements in environmental performance and record-setting philanthropic contributions."Our progress as a compan

    4/21/26 1:00:00 PM ET
    $WYNN
    Hotels/Resorts
    Consumer Discretionary

    $ADCT
    $ADGI
    $APT
    $ATIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Fertitta Tilman J

    4 - WYNN RESORTS LTD (0001174922) (Issuer)

    4/21/26 6:00:18 PM ET
    $WYNN
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 4 filed by Van Well Daan

    4 - SOPHiA GENETICS SA (0001840706) (Issuer)

    4/21/26 4:04:38 PM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Valente Manuela

    4 - SOPHiA GENETICS SA (0001840706) (Issuer)

    4/21/26 4:04:47 PM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: Large owner Donahue Kevin Michael bought $1,034,350 worth of shares (685,000 units at $1.51) (SEC Form 4)

    4/A - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/20/26 10:29:36 AM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Donahue Kevin Michael bought $258,827,700,000 worth of shares (643,850 units at $402,000.00) (SEC Form 4)

    4 - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/16/26 3:42:37 PM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (ORIG-1) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 04/23/2021. Application Category: BLA, Application Number: 761196, Application Classification:

    4/23/21 1:46:03 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    Financials

    Live finance-specific insights

    View All

    Orchid Island Capital Announces First Quarter 2026 Results

    VERO BEACH, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid" or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended March 31, 2026. First Quarter 2026 Results Net loss of $(20.0) million, or $0.11 per common share, which consists of:Net interest income of $57.1 million, or $0.30 per common shareTotal expenses of $7.4 million, or $0.04 per common shareNet realized and unrealized losses of $69.6 million, or $0.37 per common share, on RMBS and derivative instruments, including net interest income on interest rate swapsFirst quarter dividends declared and paid of $0.36 per com

    4/23/26 4:05:00 PM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    Las Vegas Sands Reports First Quarter 2026 Results

    For the quarter ended March 31, 2026Net Revenue Increased 25.3% to $3.59 billionNet Income Increased 57.1% to $641 millionDiluted Earnings per Share Increased 73.5% to $0.85 per Share Consolidated Adjusted Property EBITDA Increased 24.6% to $1.42 billionLVS Repurchased $740 million of Common StockLAS VEGAS, April 22, 2026 /PRNewswire/ -- Las Vegas Sands (NYSE:LVS), the leading global developer and operator of Integrated Resorts, today reported financial results for the quarter ended March 31, 2026."We continued to execute our strategic objectives during the quarter as we delivered growth in both Singapore and Macao while continuing to increase the return of capital to shareholders," said Pat

    4/22/26 4:05:00 PM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

    BOSTON and ROLLE, Switzerland, April 21, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the first quarter 2026 before U.S. markets open on Tuesday, May 5, 2026. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the websi

    4/21/26 8:00:00 AM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Smith-Midland Corporation

    SC 13D/A - SMITH MIDLAND CORP (0000924719) (Subject)

    12/10/24 3:10:37 PM ET
    $SMID
    Building Materials
    Industrials

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/2/24 4:57:34 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    Leadership Updates

    Live Leadership Updates

    View All

    JPMorganChase Partners With Sports Legends to Help Athletes Master Their Money

    Athlete Council to guide JPMorganChase in new programs for athletes JPMorganChase today announced a new initiative to help athletes navigate every aspect of their financial lives, from early career stages through retirement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318551874/en/Names listed in photo order from left to right for each row. Building on the firm's extensive banking and wealth planning and management expertise, the JPMorganChase Athlete Council brings together some of the world's most accomplished sports figures who will meet with JPMorganChase leaders on a periodic basis to discuss the unique financial ne

    3/18/26 12:30:00 PM ET
    $JPM
    Major Banks
    Finance

    Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

    BERKELEY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that Robert P. Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Mr. Liscouski and the change of Company name will become effective at the Company's extraordinary general meeting, being planned for April 2026. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on M

    3/11/26 7:30:00 AM ET
    $MYNZ
    $QUBT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Dingdong Announces Change in CEO

    SHANGHAI, March 4, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced the resignation of Mr. Changlin Liang as Chief Executive Officer of the Company and the appointment of Mr. Song Wang as the new Chief Executive Officer of the Company, concurrently with his resignation as Chief Financial Officer, effective March 4, 2026. Mr. Liang will continue to serve as Chairman of the Company's Board of Directors (the "Board"). As the founder of the Company, Mr. Liang has served as Chairman of the Board and Chief Executive Officer since the inception of th

    3/4/26 6:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary